3Rubin LA,Nelson DL.The Sobuble-interleukine receptor:biology function and clinical application.Ann Inter Med,1990,113:614.
4Robb RL.Conversion of lov-affinity interliukin-2 receptor to ligh-affinity state following fussion of cell membrance.Proc.Natl Acand Sci USA,1986,83:3992.
5Vincent RG,Chu TM,Lane WW.The value of carcinoembryonic antigen in patients with carcinoma of the lung.Cancer,1979,44(2):685.
6Satoh H,Ishikawa H,Kurishima K,et al.Cut-off levels of NSE to differentiate SCLC from NSCLC.Oncol Rep,2002,9(3):581.
7Broers JL,Rot MK,Oostendorp T,et al.Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial,neuronal,and neuroendocrine antigens.Cancer Res,1987,47 (12):3225.
8Giovanella L,Ceriani L,Bandera M,et al.Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation.Q J Nucl Med,1995,39(4):285.
9Giovanella L,Piantanida R,Ceriani L,et al.Immunoassay of neuronspecific enolase (NSE)and serum fragments of cytokeratin 19 (CYFRA 21.1) as tumor markers in small cell lung cancer:clinical evaluation and biological hypothesis.Int J Biol Markers,1997,12(1):22.
10Moro D,Villemain D,Vuillez JP,et al.CEA,CYFRA21-1 and SCC in non-small cell lung cancer.Lung Cancer,1995,13(2):169.
